MX2011007049A - Metodos para identificar inmunoligadores de los antegenos de la superficie celular. - Google Patents

Metodos para identificar inmunoligadores de los antegenos de la superficie celular.

Info

Publication number
MX2011007049A
MX2011007049A MX2011007049A MX2011007049A MX2011007049A MX 2011007049 A MX2011007049 A MX 2011007049A MX 2011007049 A MX2011007049 A MX 2011007049A MX 2011007049 A MX2011007049 A MX 2011007049A MX 2011007049 A MX2011007049 A MX 2011007049A
Authority
MX
Mexico
Prior art keywords
reinforcing layer
methods
layer
surface antigens
high temperature
Prior art date
Application number
MX2011007049A
Other languages
English (en)
Inventor
Valerie Hulmann-Cottier
Original Assignee
Esbatech Alcon Biomed Res Unit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42631310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2011007049(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/CH2009/000222 external-priority patent/WO2009155726A2/en
Application filed by Esbatech Alcon Biomed Res Unit filed Critical Esbatech Alcon Biomed Res Unit
Publication of MX2011007049A publication Critical patent/MX2011007049A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/5052—Cells of the immune system involving B-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Abstract

La invención propone los métodos para identificar inmunoligadores, como pueden ser anticuerpos scFv, con capacidad para unirse específicamente a los antígenos de la superficie celular, y las composiciones identificadas de acuerdo con los métodos.
MX2011007049A 2009-02-24 2010-02-22 Metodos para identificar inmunoligadores de los antegenos de la superficie celular. MX2011007049A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15504109P 2009-02-24 2009-02-24
US15510509P 2009-02-24 2009-02-24
CH8322009 2009-06-02
PCT/CH2009/000222 WO2009155726A2 (en) 2008-06-25 2009-06-25 Humanization of rabbit antibodies using a universal antibody framework
PCT/CH2010/000044 WO2010096941A1 (en) 2009-02-24 2010-02-22 Methods for identifying immunobinders of cell-surface antigens

Publications (1)

Publication Number Publication Date
MX2011007049A true MX2011007049A (es) 2011-08-03

Family

ID=42631310

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007049A MX2011007049A (es) 2009-02-24 2010-02-22 Metodos para identificar inmunoligadores de los antegenos de la superficie celular.

Country Status (10)

Country Link
US (7) US8227199B2 (es)
EP (2) EP2321354B2 (es)
JP (1) JP5764071B2 (es)
KR (1) KR101595808B1 (es)
CN (1) CN102239181A (es)
AU (1) AU2010217120B2 (es)
CA (1) CA2744103C (es)
IL (1) IL212738A (es)
MX (1) MX2011007049A (es)
WO (1) WO2010096941A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2307458B1 (en) * 2008-06-25 2018-04-11 ESBATech, an Alcon Biomedical Research Unit LLC Humanization of rabbit antibodies using a universal antibody framework
EP2307457B2 (en) * 2008-06-25 2022-06-22 Novartis AG Stable and soluble antibodies inhibiting tnf
AU2010217120B2 (en) 2009-02-24 2014-11-20 Novartis Ag Methods for identifying immunobinders of cell-surface antigens
TWI386645B (zh) * 2010-07-19 2013-02-21 Univ Kaohsiung Medical 可定量任何聚乙二醇分子與其修飾物之抗聚乙二醇表現細胞
US9329180B2 (en) * 2010-07-19 2016-05-03 Kaohsiung Medical University Preparation of anti-PEG antibody expressing cell and application thereof
PE20140772A1 (es) 2010-11-08 2014-07-03 Novartis Ag Polipeptidos que se enlazan a cxcr2
US8748587B2 (en) 2011-06-02 2014-06-10 Novartis Ag Molecules and methods for modulating TMEM16A activities
RU2017127486A (ru) * 2011-11-23 2019-02-06 Ф. Хоффманн-Ля Рош Аг Клетки млекопитающих, экспрессирующие лиганд cd40l, и их применение
US9328174B2 (en) 2012-05-09 2016-05-03 Novartis Ag Chemokine receptor binding polypeptides
US9045546B2 (en) 2012-05-31 2015-06-02 Novartis Ag Molecules and methods for modulating TMEM16A activities
US10370651B2 (en) 2013-06-28 2019-08-06 X-Body, Inc. Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes
US20160238613A1 (en) * 2013-09-30 2016-08-18 X-Body, Inc. Antigen receptor screening assay
CN111413298A (zh) * 2020-05-27 2020-07-14 深圳市天安至远传感科技有限公司 一种光纤表面等离子体共振传感器、制备方法及检测系统
WO2022120215A1 (en) * 2020-12-03 2022-06-09 The Johns Hopkins University Nanobodies with specific affinity for voltage gated sodium channels

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US20030036092A1 (en) * 1991-11-15 2003-02-20 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
US5675063A (en) * 1995-02-28 1997-10-07 Loyola University Of Chicago Immortalized rabbit hybridoma fusion partner
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
ES2176484T3 (es) 1995-08-18 2002-12-01 Morphosys Ag Bancos de proteinas/(poli)peptidos.
ATE253593T1 (de) 1996-07-16 2003-11-15 Plueckthun Andreas Prof Dr Immunglobulin-superfamilie domainen und fragmente mit erhöhter löslichkeit
WO1998049286A2 (en) * 1997-05-01 1998-11-05 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
US6060272A (en) * 1997-05-07 2000-05-09 Human Genome Sciences, Inc. Human G-protein coupled receptors
FR2777007B1 (fr) * 1998-04-01 2000-05-26 Orstom Mutants de glycoproteines d'enveloppes de retrovirus et leurs applications biologiques
US7157418B1 (en) * 1998-07-22 2007-01-02 Osprey Pharmaceuticals, Ltd. Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
US6905668B1 (en) 1998-09-25 2005-06-14 Tokyo Gas Company Limited Diagnostic agents for pancreatic exocrine function
DE19852800C1 (de) 1998-11-16 2000-04-13 Univ Albert Ludwigs Freiburg Verfahren zur Herstellung von Antikörpern gegen ein Polypeptid, von dem die kodierende Nukleinsäure bekannt ist
JP4774551B2 (ja) * 1999-01-13 2011-09-14 アルトロパス ゲーエムベーハー 抗癌ワクチン接種のための抗体の使用
CA2421447C (en) 2000-09-08 2012-05-08 Universitat Zurich Collections of repeat proteins comprising repeat modules
CN1487996B (zh) 2000-11-30 2010-06-16 米德列斯公司 用于生产人类抗体的转基因转染色体啮齿动物
EP1506236B1 (en) 2002-05-22 2013-01-23 ESBATech - a Novartis Company LLC Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
US20040067496A1 (en) * 2002-10-07 2004-04-08 Robert Pytela System for production and screening of monoclonal antibodies
CA2505924A1 (en) 2002-11-13 2004-05-27 Micromet Ag Method for identifying antigen specific b cells
CA2507004A1 (en) 2002-12-03 2004-06-17 Celltech R & D Limited Assay for identifying antibody producing cells
JP4336812B2 (ja) * 2003-03-07 2009-09-30 博夫 岩田 細胞に発現する表面抗原を迅速に同定するための分析方法
DE10314412A1 (de) 2003-03-28 2004-10-14 Genovac Ag Genetische Immunisierung mit multiplen Expressionskonstrukten zur Herstellung von monoklonalen Antikörpern
CN1787798A (zh) 2003-05-13 2006-06-14 日清奥利友集团株式会社 油性化妆品
US20070087331A1 (en) * 2003-05-15 2007-04-19 Cytos Biotechnology Ag Selection of b cells with specificity if interest: method of preparation and use
CN100415765C (zh) * 2003-08-07 2008-09-03 宜康公司 兔单克隆抗体的人源化方法
JP2004107355A (ja) 2003-10-20 2004-04-08 Kokyu Alcohol Kogyo Co Ltd 油性固形化粧料
CN100451012C (zh) 2003-11-20 2009-01-14 三菱瓦斯化学株式会社 液态环己烷-三羧酸酐
EP1745066A2 (en) * 2004-03-18 2007-01-24 Board of Regents, The University of Texas System Combinatorial protein library screening by periplasmic expression
CN101171263A (zh) * 2005-03-04 2008-04-30 比奥根艾迪克Ma公司 通过合理修饰互补决定区残基使免疫球蛋白可变区人源化的方法
EP2343363A1 (en) * 2005-07-01 2011-07-13 John Schrader Methods of isolating cells and generating monoclonal antibodies involving single epitope multiple staining
US20070134249A1 (en) * 2005-12-08 2007-06-14 Genitope Corporation Combination therapy and antibody panels
US8017119B2 (en) 2005-12-28 2011-09-13 Daiichi Sankyo Company, Ltd. Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
EP1918302A3 (en) 2006-05-18 2009-11-18 AvantGen, Inc. Methods for the identification and the isolation of epitope specific antibodies
PT2374818E (pt) * 2006-06-02 2013-02-13 Regeneron Pharma Anticorpos com elevada afinidade para o receptor il-6 humano
EP3093026B1 (en) 2006-07-10 2020-07-01 ESBATech, an Alcon Biomedical Research Unit LLC Scfv antibodies which pass epithelial and/or endothelial layers
AU2007338607B2 (en) * 2006-12-20 2013-03-14 Mmrglobal, Inc. Antibodies and methods for making and using them
JP2010222255A (ja) * 2007-06-18 2010-10-07 Mitsubishi Tanabe Pharma Corp 抗体のスクリーニング方法およびそれにより得られる抗体
JP5022818B2 (ja) 2007-08-10 2012-09-12 株式会社 資生堂 毛髪化粧料
EP2307458B1 (en) 2008-06-25 2018-04-11 ESBATech, an Alcon Biomedical Research Unit LLC Humanization of rabbit antibodies using a universal antibody framework
KR101817284B1 (ko) 2008-06-25 2018-01-11 에스바테크 - 어 노바티스 컴파니 엘엘씨 Ｖｅｇｆ를 억제하는 안정하고 가용성인 항체
EP2307457B2 (en) 2008-06-25 2022-06-22 Novartis AG Stable and soluble antibodies inhibiting tnf
AU2010217120B2 (en) 2009-02-24 2014-11-20 Novartis Ag Methods for identifying immunobinders of cell-surface antigens
JP5926896B2 (ja) 2010-09-17 2016-05-25 株式会社 資生堂 唇用固形化粧料

Also Published As

Publication number Publication date
AU2010217120B2 (en) 2014-11-20
US8465937B2 (en) 2013-06-18
US9908940B2 (en) 2018-03-06
US20160152716A1 (en) 2016-06-02
JP5764071B2 (ja) 2015-08-12
IL212738A (en) 2015-04-30
IL212738A0 (en) 2011-07-31
US20190382498A1 (en) 2019-12-19
US20180142028A1 (en) 2018-05-24
EP2321354A1 (en) 2011-05-18
US20120288878A1 (en) 2012-11-15
JP2012518390A (ja) 2012-08-16
AU2010217120A1 (en) 2010-09-02
EP2321354B2 (en) 2019-11-20
CN102239181A (zh) 2011-11-09
CA2744103C (en) 2018-01-02
US8227199B2 (en) 2012-07-24
CA2744103A1 (en) 2010-09-02
US20100216170A1 (en) 2010-08-26
WO2010096941A1 (en) 2010-09-02
US9221905B2 (en) 2015-12-29
KR20110136783A (ko) 2011-12-21
KR101595808B1 (ko) 2016-02-19
US20130090456A1 (en) 2013-04-11
US20150024432A1 (en) 2015-01-22
EP3181583A1 (en) 2017-06-21
EP2321354B1 (en) 2016-12-07

Similar Documents

Publication Publication Date Title
MX2011007049A (es) Metodos para identificar inmunoligadores de los antegenos de la superficie celular.
EP2137450A4 (en) FLEXIBLE COMPOSITE TUBULAR ASSEMBLY WITH HIGH ISOLATION PROPERTIES AND METHOD OF MANUFACTURING THE SAME
WO2010059736A3 (en) Near-field transducers for focusing light
WO2009135181A3 (en) Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
HK1153168A1 (en) Installation-ready pipe coupling method of manufacture
WO2009112245A9 (en) Antibody against the csf-1 r
GB0807398D0 (en) Improved method of tape laying of thermoplastic composite materials
WO2011106723A3 (en) Anti-paf antibodies
EP2657296A4 (en) HALOGEN-FREE RESIN COMPOSITION AND METHOD FOR PRODUCING A HALOGEN-FREE COPPER-COATED LAMINATE THEREWITH
IL239947A0 (en) Monoclonal antibodies against 21-il of human origin
IL212701A0 (en) Improved anti-cd19 antibodies
WO2013155514A3 (en) Pipe section having bonded composite barrier layer
IL212099A (en) Bi-specific antibody with single chain CD3 epsilon and prostate-specific membrane antigen, preparations containing them and uses
EP2750144A4 (en) SUBMARINE CABLE, MULTILAYER TAPE FOR A WATER SHIELDING LAYER OF A SUBMARINE CABLE, AND METHOD FOR IMPROVING FATIGUE CHARACTERISTICS OF A SUBMARINE CABLE
HUE038432T2 (hu) Nyúl antitestek humanizálása egy univerzális antitest keret alkalmazásával
EP2390998A4 (en) DIELECTRIC FILM, METHOD FOR ITS MANUFACTURE AND CONVERTER THEREFOR
IL214836A (en) Antibodies against Mx (epsilon) c-anti or antibody-binding antibody segments and their use
MX2009004167A (es) Anticuerpos que enlazan epitopos cxcr7.
HK1155790A1 (en) Heat insulator for vehicle exhaust pipe and method for manufacturing the same
WO2014028444A3 (en) High temperature flow-line insulation
EP2331689A4 (en) METHOD OF CLONING AVIAN ORIGIN ANTIBODIES
EP2401750A4 (en) METHOD FOR MANUFACTURING A COAXIAL CABLE INCLUDING A BIMETALLIC TUBULAR INTERNAL LAYER WITH FOLDED EDGE PARTS
WO2009138971A3 (en) Skin cured ptfe wire and cable
MX353725B (es) Métodos para fabricar alambres, pre-productos de alambre y alambres de capas múltiples.
EP2053297A3 (en) Coupling construction for high-pressure pipe